Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs HBM✓SelectedUSD · HBMMRNA vs HBM performance historyLatest closeAs of-4.84%11/18
Stock and ETF performance explorer

MRNA vs HBM

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-21.7%
HBM return
+157.7%
Excess return
-179.4%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioHBMExcessAlpha
1D-4.8%-8.6%+3.7%-2.3%
7D-20.9%-17.7%-3.1%-16.2%
30D-13.3%-24.5%+11.3%-5.4%
3M+212.6%-31.6%+244.2%+251.0%
6M+309.0%-25.6%+334.6%+344.7%
YTD+567.3%-9.0%+576.3%+582.7%
1Y+689.7%+19.6%+670.1%+658.8%
3Y+157.4%+319.4%-162.0%+80.6%
5Y-21.7%+159.5%-181.3%-41.1%
All-21.7%+157.7%-179.4%-41.1%

Cumulative growth

Daily Returns

Daily percentage return beside HBM.

Daily Out/Under-Performance

Portfolio return minus HBM return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × HBM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded HBM wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling